Healthcare Sector Analysis, Overview and Companies Reports (Page 1)

Company Name	Industry Name	Latest Price (Rs.)	Price Change Rs (%)	Market Cap	Net Sales (Rs. Cr.)	Latest EPS (Rs.)	Net Profit Margin %	Latest P/E	Latest P/BV
Alembic Pharma	Pharmaceuticals & Drugs	745.6	8.6 (1.17%)	Small Cap	6,672	34.3	8.29	21.7	2.6
Piramal Pharma	Pharmaceuticals & Drugs	165.4	-1.35 (-0.81%)	Small Cap	5,286	5.3	13.11	31.5	2.7
Natco Pharma	Pharmaceuticals & Drugs	868.6	-25.05 (-2.8%)	Small Cap	4,430	79.2	40.5	11	1.7
Emcure Pharma	Pharmaceuticals & Drugs	1,719.6	-40.95 (-2.33%)	Small Cap	4,382	38.7	6.24	44.5	8.8
Aster DM Healthcare	Hospital & Healthcare Services	766.1	12.5 (1.66%)	Small Cap	4,138	7.5	8.01	102.3	8.7
Gland Pharma	Pharmaceuticals & Drugs	2,247.6	-24.55 (-1.08%)	Small Cap	4,116	78.8	26.26	28.5	3.4
JB Chem & Pharma	Pharmaceuticals & Drugs	2,172.1	2.6 (0.12%)	Small Cap	3,890	42	17.14	51.7	8.6
Global Health	Hospital & Healthcare Services	1,212.8	-26.75 (-2.16%)	Small Cap	3,204	18.5	15.48	65.7	8.1
Granules India	Pharmaceuticals & Drugs	767	-22.6 (-2.86%)	Small Cap	3,030	16.2	9.87	47.4	4.3
Wockhardt	Pharmaceuticals & Drugs	1,893.7	-26.5 (-1.38%)	Small Cap	3,012	13.1	-1.8	144.5	6.2
Eris Lifesciences	Pharmaceuticals & Drugs	1,365.1	4 (0.29%)	Small Cap	2,894	44.7	12.9	30.5	4.9
Dishman Carbogen Amc	Pharmaceuticals & Drugs	184.1	-6 (-3.16%)	Small Cap	2,712	6.2	0.85	29.6	0.4
Aarti Drugs	Pharmaceuticals & Drugs	365.6	-11.5 (-3.05%)	Small Cap	2,387	21.4	7.04	17.1	2.2
Alivus Life Sciences	Pharmaceuticals & Drugs	1,000.6	-30.35 (-2.94%)	Small Cap	2,387	46	20.07	21.8	3.7
Dr. Lal Pathlabs	Hospital & Healthcare Services	1,545.6	9.6 (0.63%)	Small Cap	2,352	30.3	21.21	51	10.5
Pfizer	Pharmaceuticals & Drugs	4,531.1	75.85 (1.7%)	Small Cap	2,281	157.9	28.39	28.7	4.9
Strides Pharma Scien	Pharmaceuticals & Drugs	1,005.2	-37.75 (-3.62%)	Small Cap	2,139	19.9	2.46	50.5	2.8
IOL Chem & Pharma	Pharmaceuticals & Drugs	127	-4.6 (-3.5%)	Small Cap	2,079	4.7	4.59	27.1	2.1
FDC	Pharmaceuticals & Drugs	381.1	0.3 (0.08%)	Small Cap	2,070	17.6	12.16	21.7	2.5
Caplin Point Lab	Pharmaceuticals & Drugs	2,110	78.55 (3.87%)	Small Cap	1,937	84.4	27.17	25	4.5
Hikal	Pharmaceuticals & Drugs	179.7	-10.1 (-5.32%)	Small Cap	1,860	-4	4.72	-	1.9
Sanofi India	Pharmaceuticals & Drugs	3,162.5	-21.25 (-0.67%)	Small Cap	1,837	134.5	18.75	23.5	9.3
Aarti Pharmalabs	Pharmaceuticals & Drugs	606	-23.45 (-3.73%)	Small Cap	1,771	19.4	14.41	31.2	2.8
Unichem Lab	Pharmaceuticals & Drugs	357.2	-5.7 (-1.57%)	Small Cap	1,736	22.6	8.09	15.8	1
Astrazeneca Pharma I	Pharmaceuticals & Drugs	8,383.4	-215.2 (-2.5%)	Small Cap	1,716	75	10.69	111.8	24

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Healthcare - Sector Analysis and Overview

Find out the best companies in the Industry/ Sector/ Index of your choice, based on critical criteria.

Select a category :

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.